Platelet‐Activating Factor Antagonist BN52021 Decreases Accumulation of Free Polyunsaturated Fatty Acid in Mouse Brain During Ischemia and Electroconvulsive Shock

Journal of Neurochemistry

Volumn 51, Issue 6, 1988, Pages 1900-1905

  Birkle, Dale L ^a   Kurian, Pawels ^a   Braquet, Pierre ^b   Bazan, Nicolas G ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b Institut Henri Beaufour   (France)

Author keywords

Arachidonic acid; Diacylglycerols; Phosphoinositides; Phospholipase; Platelet activating factor

Indexed keywords

ARACHIDONIC ACID; DIACYLGLYCEROL; GINKGOLIDE B; LYSOPHOSPHOLIPASE; PHOSPHOLIPASE A2; POLYUNSATURATED FATTY ACID; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN ISCHEMIA; ELECTROCONVULSIVE THERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; LIPID METABOLISM; MOUSE; NONHUMAN; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL;

ANIMAL; BRAIN; BRAIN ISCHEMIA; CHROMATOGRAPHY; DIGLYCERIDES; DIMETHYL SULFOXIDE; ELECTROSHOCK; FATTY ACIDS, NONESTERIFIED; LACTONES; MALE; MICE; MICE, INBRED BALB C; PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE; PHOSPHATIDYLINOSITOLS; PLANT EXTRACTS; PLATELET ACTIVATING FACTOR; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024231988     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.1988.tb01175.x     Document Type: Article

References (30)

1. Differential lipid deacylation during brain ischemia in a homeotherm and a poikilotherm. Content and composition of free fatty acids and triacylglycerols
2. Rapid production of diacylglycerols enriched in arachidonate and stearate during early brain ischemia
3. Changes in cytosolic free calcium in rabbit platelets: specific inhibition by BN52021 and structurally related compounds
4. Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain
5. Free arachidonic acid and other lipids in the nervous system during early ischemia and after electroshock.
6. The accumulation of free arachidonic acid, diacylglycerols, prosta‐glandins, and lipoxygenase reaction products in the brain during experimental epilepsy
7. Decreased content of docosahexaenoate and arachidonate in plasma phospholipids in Usher's syndrome
8. Inhibition of polyunsaturated fatty acid accumulation in mouse brain during electroconvulsive shock and ischemia by the specific PAF antagonist, BN52021. (Abstr)
9. Perspectives in platelet activating factor research.
10. Production of platelet‐activating factor by chick retina.
11. PAF and PAF antagonists
12. Effects of Ginkgo biloba extract on cerebral metabolic processes
13. 1‐O‐Alkyl 2‐arachidonoyl‐in‐glycero‐3‐phosphocholine. A common source of platelet activating factor and arachidonate in human polymorphonuclear leukocytes
14. Role of dimethyl sulfoxide in prostaglandin‐thromboxane and platelet systems after cerebral ischemia.
15. Antiplatelet effect of dimethylsulfate, barbiturates and methyl prednisone.
16. Acidic phospholipids, diacyl‐glycerols, and free fatty acids in gerbil brain: a comparison of ischemic changes resulting from carotid ligation and decapitation.
17. Polyphosphoinositides as a probable source of brain free fatty acids accumulated at the onset of ischemia.
18. Effect of an extract of Ginkgo biloba on rat brain energy metabolism in hypoxia.
19. Stimulation of calcium uptake in neural cells by the alkyl‐ether phospholipid platelet activating factor (PAF). (Abstr)
20. Influence of an extract of Ginkgo biloba on cerebral blood flow and metabolism.
21. Inhibition of transmembrane movement and metabolism of platelet activating factor (PAF‐acether) by a specific antagonist, BN52021
22. Effects of Ginkgo biloba on changes induced by quantitative cerebral microembolization in rats.
23. Biosynthesis and metabolism of l‐O‐alkyl‐2‐acetyl‐sn‐glycero‐3‐phosphocholine in rat glomerular mesangial cells.
24. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride‐methanol.
25. Effects of a platelet activating factor antagonist (BN52021) on free fatty acids, diacylglycerols, polyphosphoinositides and blood flow in the gerbil brain: inhibition of ischemia‐reperfusion induced cerebral injury.
26. Arachidonic acid, stearic acid and diacylglycerol accumulation correlates with the loss of phosphatidylinositol4,5‐bisphosphate in cerebrum two sec after electroconvulsive shock.
27. Involvement of platelet‐activating factor (PAF) in cerebral postischemic phase in Mongolian gerbils
28. Synthesis in vitro of l‐alkyl‐2‐acyl and1,2‐diacyl‐sn‐glycerophosphorylcholines and ethanolamines by neuronal, glial and synaptosomal fractions from adult rabbit brain.
29. Electroconvulsive shock stimulates polyphosphoinositide degradation and inositol trisphosphate accumulation in rat cerebrum: lithium pretreatment does not potentiate these changes.
30. Ischemic brain injury: the importance of calcium, lipolytic activities and free fatty acids.